ArticlePediatric gastroenterology, hepatology & nutrition2026

Week 14 Infliximab Level Provides Modest Benefit to Clinical Outcomes in Children with Crohn's Disease.

Asha Jois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.